Cresilon

Cresilon Cresilon, Inc. is a medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments.

Headquartered in Brooklyn, New York, Cresilon, Inc. is a privately-held medical device company focused on hemostatic technologies that improve wound care and advance the standard of medical treatments. For more information, visit Cresilon.com.

--
DISCLAIMER: The products and the claims made about specific products on or through this site have not been evaluated by the United States Food and Drug

Administration (FDA) and are not approved to diagnose, treat, cure, or prevent disease. This notice will be updated upon FDA approval.

06/09/2026

See how TRAUMAGEL® stands out to these EMTs.

“What stood out most to me was how quick it was to learn how to use, and how quickly it completely stopped bleeding. It worked super fast, a lot faster than anything else I’ve ever used.” - Zach Papoutsis, Firefighter/EMT, Cobb County Fire & Emergency Services

Learn more at traumagel.com

06/02/2026

“I am alive, and it saved me from losing my hand.” - Casey Bolin, Patient

Real-world feedback on TRAUMAGEL® from the field.

Learn more at traumagel.com

This Memorial Day, we remember and honor the heroes who served our nation.
05/25/2026

This Memorial Day, we remember and honor the heroes who served our nation.

We’re at the FDNY SRFM 2026 Symposium. Stop by to learn more about TRAUMAGEL®.
05/14/2026

We’re at the FDNY SRFM 2026 Symposium. Stop by to learn more about TRAUMAGEL®.

05/01/2026

We were proud to exhibit at SOMA 2026.
 
A valuable opportunity to engage with leaders across the tactical and operational medicine community.
 
Those conversations continue to inform how TRAUMAGEL® supports care when seconds matter most.
 
Grateful for the time and perspective shared throughout the week.
 

04/29/2026

Evacuation timelines can extend significantly in large-scale conflict zones, requiring prolonged field care.

Learn more about TRAUMAGEL® at Booth 514, SOMA 2026.
1. Eastridge BJ et al. Death on the battlefield (2001–2011): implications for combat casualty care. J Trauma Acute Care Surg. 2012;73(6 Suppl 5):S431–7. doi:10.1097/TA.0b013e3182755dcc

04/29/2026

TRAUMAGEL® controls bleeding in seconds.

Learn more about TRAUMAGEL® at Booth 514, SOMA 2026.

1. Yatsun V. Application of hemostatic tourniquet on wounded extremities in modern “trench” warfare. Mil Med. 2022;usac208. doi:10.1093/milmed/usac208

04/29/2026

Uncontrolled hemorrhage remains the leading cause of preventable death in combat. When seconds matter, rapid bleeding control can make the difference.

Stop by Booth 514 at SOMA 2026 to learn more about TRAUMAGEL®

1. Russ S. Kotwal et al., Eastridge BJ et al. Died of wounds on the battlefield: causation and implications for improving combat casualty care. J Trauma. 2011;71(1 Suppl):S4–8. doi:10.1097/TA.0b013e318221147b

NEWS: TRAUMAGEL® Published in JSOM (Journal of Special Operations Medicine)The Use of Traumagel for Hemorrhage Control a...
04/28/2026

NEWS: TRAUMAGEL® Published in JSOM (Journal of Special Operations Medicine)

The Use of Traumagel for Hemorrhage Control and Tourniquet Removal: A Case Series of Traumatic Extremity Injuries

A recent peer-reviewed publication highlights how TRAUMAGEL can support hemorrhage control in tactical and prolonged field care environments.

Key findings from operational use cases in traumatic hemorrhage:

- Demonstrated rapid hemorrhage control in extremity injuries
- Enabled tourniquet conversion and removal without rebleeding
- Conformed to irregular wound geometries where traditional methods are limited
- Supported durable hemostasis when used alongside standard interventions
- Showed potential to reduce risks associated with prolonged tourniquet use

These findings reinforce TRAUMAGEL’s potential as an adjunct solution in tactical casualty care, where rapid, reliable bleeding control is critical for both patient outcomes and mission success.

Read the full article in JSOM: https://pubmed.ncbi.nlm.nih.gov/42034451/

Authors: Cassidy Wheeler, Patrick Greiffenstein, Jennifer Brewer, Tyler Nicholas Carruth, Easton Stelly, Christopher McCuller

Address

122 18th Street
Brooklyn, NY
11215

Telephone

(347) 435-2226

Website

Alerts

Be the first to know and let us send you an email when Cresilon posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cresilon:

Shortcuts

Share

Category